Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
6.14
+0.09 (1.49%)
At close: Apr 9, 2026, 4:00 PM EDT
6.05
-0.09 (-1.47%)
Pre-market: Apr 10, 2026, 5:42 AM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $985.31 million as of April 10, 2026. Its market cap has increased by 263.61% in one year.
Market Cap
985.31M
Enterprise Value
773.17M
1-Year Change
263.61%
Ranking
Category
Stock Price
$6.14
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $985.31M, an increase of 54.07%. That is a compound annual growth rate of 7.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 985.31M | 31.68% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.02B |
| Inventiva | 1.02B |
| uniQure | 993.59M |
| KalVista Pharmaceuticals | 987.06M |
| Inhibrx Biosciences | 980.57M |
| Evommune | 977.18M |
| Compass Therapeutics | 972.47M |
| Aktis Oncology | 938.59M |